Acta Scientific Paediatrics (ISSN: 2581-883X)

Case Report Volume 3 Issue 1

Resection of Recurrent Hepatoblastoma: A Case Report

Fadi Rayya1* and Turki Alhasoon2

1Department of General Surgery, Al Assad University Hospital, Faculty of Medicine, Damascus University, Syria
2General Surgery, Faculty of Medicine, Damascus University, Damascus, Syria

*Corresponding Author: Fadi Rayya, Consultant Surgeon, Department of General Surgery, Al Assad University Hospital, Faculty of Medicine, Damascus University, Syria

Received: November 28, 2019; Published: December 26, 2019



  Hepatoblastoma (HB) is considered to be one of the most common liver malignant tumors in children. A three years old male presented with a hepatic mass, which was diagnosed as recurrent Hepatoblastoma. After neoadjuvant chemotherapy the patient underwent a successful hepatectomy.

Keywords: Hepatoblastoma; Liver; Chemotherapy



  1. Steliarova-Foucher, E., et al. “International incidence of childhood cancer, 2001-10: a population-based registry study”. The Lancet Oncology 18.6 (2017): 719-731.
  2. Raney B. “Hepatoblastoma in children: a review” (1997).
  3. Mukhopadhyay P., et al. “Adult hepatoblastoma in a female downs”. Journal of Association of Physicians of India 55 (2007): 242-243.
  4. Fabre M and Bouvier R. “Tumeurs du foie de l enfant”. In: Groupe Metavir. Patologie tumorale du foie. Elsevier, Paris (2002).
  5. Brown J., et al. “Pretreatment prognostic factors for children with hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1”. European Journal of Cancer (Oxford, England: 1990) 36.2 (2000): 1418-1425.
  6. Douglass EC., et al. “Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group study”. Journal of Clinical Oncology 11 (1993): 96-99.
  7. Czauderna P., et al. “Hepatoblastoma state of the art: Pathology, genetics, risk stratification, and chemotherapy”. Current Opinion in Pediatrics (2014).
  8. Czauderna P., et al. “Guidelines for surgical treatment of hepatoblastoma in the modern era--recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL)”. European Journal of Cancer (Oxford, England: 1990) 41 (2005): 1031-1036.
  9. Semeraro M., et al. “Relapses in hepatoblastoma patients: Clinical characteristics and outcome-Experience of the International Childhood Liver Tumour Strategy Group (SIOPEL)”. European Journal of Cancer 49 (2013): 915-922.
  10. Kachanov Denis and Shamanskaya T. “Long-term Follow Up of Patients with Hepatoblastoma”. Russian Journal of Children Hematology and Oncology (2015): 78-89.
  11. Trobaugh-Lotrario AD and Feusner JH. “Relapsed hepatoblastoma”. Pediatric Blood and Cancer 59.5 (2012): 813-817.


Citation: Fadi Rayya and Turki Alhasoon. “Resection of Recurrent Hepatoblastoma: A Case Report”.Acta Scientific Paediatrics 4.1 (2020): 36-38.

Member In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 30, 2020.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US